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CORRESPONDENCE
Response to comments on ‘‘Separation of Components
in Fenestrated and Branched Endovascular Grafting’’
Dear Editor,
Multiple factors contribute to destabilization forces, but
cross-sectional area reduction and angulation within the
graft overwhelmingly constitute the major components of
load, and thus device displacement forces.1e4 Devices are
distorted in a downward direction unless otherwise
opposed, so require enough strength to resist displace-
ment, and the ability to deal with the potential for
morphologic change. In truth, all endografts represent
some combination of the two.
Migration is unacceptable, particularly when branches
are incorporated into the repair.5 When planning a device
incorporating visceral branches, we strive for absolute
fixation of the device to the proximal and distal landing
sites in concert with mechanisms to allow the graft to
accommodate to any morphologic changes. The example
cited by Scurr reflects that an uncovered bare stent with
barbs, and a sealing stent deployed within parallel aorta
provide good proximal fixation, and the distal portion of the
iliac limb fixation is also adequate (Fig. 1). However,
the bifurcation of the device is deployed quite high within
the aneurysm sac, allowing the bifurcated component to
‘‘sit down’’ in the aneurysm, kinking the limbs. This picture
is reminiscent of the behavior of a Vanguard graft.6 The
current fenestrated graft design involves intentionally little
fixation but extensive overlap between the fenestrated
bifurcate component and the tubular component incorpo-
rating the branches, allowing the component relationship
to safely change as the grafts adjust to the aneurysm
morphology. Yet the proper implementation of this design
requires proper planning, or limb kinking and component
separation may occur (which is extremely uncommon in the
published series).
The first answer is that most patients implanted with
a device do not have sufficient inter-component move-
ment observed to result in such a complication. In our
article only 13% of the 500 branched and fenestrated
patients had more than 10 mm of component movement,7
but a small group or patients did have considerable
movement noted. However, when we reviewed our entire
experience, dating back to 2001, there were only 2 late
(>30 day) limb thromboses, one of which did in fact,
occur by the mechanism described by Scurr, where the
iliac bifurcation was mistakenly planned high up in the
aneurysm sac.
The low prevalence of this complication may reflect
observations made by Dr. Wolfe Stelter in the late 1990s:
the stability of the distal component rests upon the iliac
bifurcation. Optimally, a fenestrated device has a long
tubular body that terminates within 15e25 mm of the iliac
bifurcation, and leaves the minimal space necessary to
deploy the bifurcate component. The overlap between the
tubular and bifurcate components is 4e6 stents long.
Component movement, should it occur, typically allows the
body of the graft to rest against the anterior aspect of the
Figure 1 Early images of fenestrated device that eventually
underwent distal component migration. (Image provided by
Scurr et al.) Dark/dashed arrow indicates level of device bifur-
cation. White arrow indicates aortic bifurcation (not seen).DOI of original article: 10.1016/j.ejvs.2008.06.009.
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aneurysm wall, reducing the overlap while leaving the
bifurcation and limbs stable within the distal aneurysm,
and ameliorating the proximal displacement forces.
We have experimented with alternate designs, including
locking the bifurcate portion to the tubular portion of the
device, or improving the crush resistance of stents
deployed within fenestrations. However, the same funda-
mental principles apply to any design regardless of any
subtle differences. They include the following:
(1) Ensure optimal proximal fixation (active fixation in
healthy aorta).
(2) Ensure optimal distal fixation (rest bifurcate portion on
the bifurcation and secure the limbs within healthy
segments of the iliac arteries).
(3) Ensure maximal overlap between the bifurcate and
tubular components.
(4) Allow the two components to reach a minimal stressed
state, mitigating the downward forces on the proximal
portion of the device.
These principles are adhered to in our practice, and
perhaps explain the absence of this complication in all
implants after 2004.
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Comment on ‘‘Long-Term Results using
Catheter-directed Thrombolysis in 103 Lower Limbs
with Acute Iliofemoral Venous Thrombosis’’
Dear Editor,
I have read with interest the article published by Baekgard
et al. regarding a single center’s experience with catheter
directed thrombolysis of iliofemoral venous thrombosis.1
This article demonstrates potential benefits of thrombolysis
in the treatment of deep vein thrombosis, especially in the
prevention of late complications. However, some additional
data would have been helpful. Anticoagulant treatment
may affect recurrence rate and therefore, indirectly, local
complication rate. Treatment duration is a matter of
debate but probably should be tailored according to patient
characteristics.2,3 It would therefore have aided to our
understanding if Baekgaard and colleagues added the
information regarding their patient’s anticoagulation regi-
mens and adherence. Furthermore, graded compression
stockings may have yet another beneficial effect in pre-
venting the post-phlebitic syndrome.4 Report of the use of
such devices in the studied population could have added
more to our understanding of the actual benefits of cath-
eter directed thrombolysis in preventing late complications
of deep vein thrombosis.
Thank you.
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